EOCN · Eocene Ltd
United States · RS rating 7 · As of 2026-10-14
| Price | 3.01 USD |
|---|---|
| 1-day change | -4.9% |
| RS rating (overall / 1M / 3M / 12M) | 7 / 14 / 11 / 8 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 21 / 19 / 31 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -23.3% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +74.4% |
| Market cap (USD) | $3.9M |